Sexual Health
STI 12-Panel
Multiplex real-time PCR covering twelve sexually transmitted infection targets.
Format
Multiplex real-time PCR
Manufactured in
Jeddah · KSA
Quality system
ISO 13485 aligned
GMP
WHO GMP aligned
Overview
The Gene Matrix STI 12-Panel is a multiplex real-time PCR assay designed to detect twelve clinically relevant sexually transmitted infection targets from a single sample — streamlining laboratory workflows and supporting comprehensive sexual-health programmes. HPV is intentionally excluded from this panel and is offered as a dedicated genotyping kit.
Clinical Context
- Co-infection with multiple STI pathogens is common; single-target testing can miss clinically actionable findings.
- A multiplex panel improves diagnostic yield and reduces time-to-result for patients and clinicians.
- Designed for high-throughput laboratory settings and sexual-health clinics across the Kingdom and the region.
Target Panel — 12 STI Pathogens
| Parameter | Detail |
|---|---|
| Targets | Chlamydia trachomatis · Neisseria gonorrhoeae · Trichomonas vaginalis · Mycoplasma genitalium · Mycoplasma hominis · Ureaplasma urealyticum · Ureaplasma parvum · Treponema pallidum · Herpes simplex virus 1 (HSV-1) · Herpes simplex virus 2 (HSV-2) · Haemophilus ducreyi · Gardnerella vaginalis |
| Internal control | Endogenous human gene control |
| Sample types | Urine, urethral and cervical swabs |
| Format | Multiplex real-time PCR |
| Note | HPV not included — see HPV Detection Kit |
Workflow
From sample to result, in four steps
- 01
Sample collection
Validated transport medium and sample types per assay specification.
- 02
Nucleic acid extraction
Compatible with major automated and manual extraction workflows.
- 03
Real-time PCR
Multiplex amplification on standard 96-well thermocyclers.
- 04
Reporting
Genotype/serotype-specific channels for clear clinical reporting.
Performance
Validated to international references
Each assay is characterised for analytical sensitivity, specificity and limit of detection against established clinical references. Full validation packs and lot-specific data are shared with prospective customers under appropriate confidentiality.
Analytical sensitivity
Validated against international reference panels
Analytical specificity
No cross-reactivity with related pathogens
Limit of detection
Lot-specific data on request
Frequently asked
Why is HPV not included in the STI panel?
HPV genotyping requires a dedicated multiplex assay to discriminate 14 high-risk genotypes — we offer it as a stand-alone kit to maintain clinical utility.
Can the panel be run on multiple sample types?
Yes. The assay is validated on urine, urethral and cervical swabs in validated transport media.
Is the panel suitable for symptomatic and screening workflows?
Both. The 12-target multiplex format supports diagnostic work-up for symptomatic patients and broader sexual-health screening.